Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria

Sanne Franzen, Jade Emily Smith, Esther van den Berg, Monica Rivera Mindt, Rozemarijn L. van Bruchem-Visser, Erin L. Abner, Lon S. Schneider, Niels D. Prins, Ganesh M. Babulal, Janne M. Papma

Research output: Contribution to journalReview articlepeer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science